GKB Ophthalmics Limited
GKB · 533212 · Healthcare · Medical Equipment & Supplies
- Market cap
- Rs 30.2 Cr
- P/E
- 9.33x
- P/B
- 0.57x
- 52W high / low
- No data: the source has not published this figure.
Our computed roe (6.19%) diverges from BSE's own published figure (-17.43%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong. Our computed operating_margin (5.51%) diverges from BSE's own published figure (-14.79%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong. Our computed net_margin (3.68%) diverges from BSE's own published figure (-29.41%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong.
About GKB Ophthalmics
GKB Ophthalmics Limited is listed on the NSE under the symbol GKB and on the BSE under scrip code 533212. It is classified in the Healthcare sector, industry: Medical Equipment & Supplies. The company listed on 17 Aug 2026 and has a face value of Rs 10.
The latest available end-of-day price is Rs 60.01 (−0.81% on the day), for a market capitalisation of Rs 30.2 Cr. Trailing P/E is 9.33x and price-to-book is 0.57x.
Against the 9-company comparison set from the official BSE basic industry Medical Equipment & Supplies, its market capitalisation is 0.7 times the peer median of Rs 45.9 Cr, and its P/E of 9.33x compares with a peer median of 19.85x. The comparison set is chosen mechanically from the exchange classification; it is not a ranking.
Latest annual results
For FY26 (year ended 31 Mar 2026), GKB Ophthalmics Limited reported revenue of Rs 149 Cr and net profit of Rs 3 Cr, with a net margin of 2.03% and earnings per share of Rs 2.42 (consolidated statements).
Year-on-year change: revenue +37.16%; net profit not meaningful (a loss in one of the periods); EPS not meaningful (a loss in one of the periods). Three-year compound annual growth rate: revenue +25.58%; net profit +196.28%.
At the same date the balance sheet shows total assets of Rs 132 Cr, shareholders' equity of Rs 52.8 Cr, total debt of Rs 11.7 Cr, cash of Rs 2.7 Cr, a debt-to-equity ratio of 0.22 and operating cash flow of Rs -3.8 Cr.
On a trailing-twelve-month basis the filings add up to revenue of Rs 150 Cr, net income of Rs 5.5 Cr and a net margin of 3.68%.
Shareholding pattern
In the shareholding pattern for 30 Sept 2026, GKB Ophthalmics Limited's ownership is split: promoters 51.15%; foreign institutional investors (FIIs) 1.79%; retail and other shareholders 48.85%.
Compared with the filing for 30 Jun 2026: promoter holding 0.00 percentage points; FII holding 0.00 percentage points.
The same filing lists reported promoter pledge of 0.00% and 2,633 shareholders on record.
Recent filings and corporate actions
42 BSE corporate announcements were filed by GKB Ophthalmics Limited in the past twelve months; the most frequent category is "Company Update" (22). The most recent is "GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to co…" (Board Meeting), filed on 29 Oct 2026.
Figures are raw disclosures from official NSE/BSE and SEBI filings plus mechanically computed ratios, restated in words. This is research data, not investment advice, a rating or a recommendation; DalalOS is not a SEBI-registered investment advisor.
More
Peer comparison
Official BSE basic industry: Medical Equipment & Supplies. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Nureca Limited | Rs 302.9 | Rs 289 Cr | Rs 160 Cr | Rs 4.3 Cr | 70.44x | 2.31% |
| Earkart Ltd | Rs 116 | Rs 160 Cr | — | — | 32.31x | — |
| Choksi Asia Ltd | Rs 211.9 | Rs 121 Cr | Rs 48 Cr | Rs 5.2 Cr | 23.29x | 13.14% |
| Shree Pacetronix Ltd | Rs 174.75 | Rs 65.5 Cr | Rs 21.3 Cr | Rs 3.2 Cr | 19.68x | 8.58% |
| Amkay Products Ltd | Rs 53 | Rs 45.9 Cr | — | — | 19.85x | — |
| Royal Sense Ltd | Rs 70 | Rs 37.5 Cr | — | — | 12.43x | — |
| GKB Ophthalmics LimitedThis company | Rs 60.01 | Rs 30.2 Cr | Rs 153 Cr | Rs 5.5 Cr | 9.33x | 6.19% |
| Centenial Surgical Suture Ltd | Rs 71.25 | Rs 26 Cr | Rs 56.4 Cr | Rs -1.4 Cr | — | -4.87% |
| Transpact Enterprises Ltd | Rs 96 | Rs 3.7 Cr | — | — | — | — |
| Median | Rs 96 | Rs 45.9 Cr | Rs 56.4 Cr | Rs 3.2 Cr | 19.85x | 2.31% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.
Companies related to GKB Ophthalmics
Same official industry (Medical Equipment & Supplies)
- Nureca LimitedNURECA · Market cap Rs 289 Cr
- Earkart LtdINE1A8F01035 · Market cap Rs 160 Cr
- Choksi Asia LtdINE865B01016 · Market cap Rs 121 Cr
- Shree Pacetronix LtdINE847D01010 · Market cap Rs 65.5 Cr
- Amkay Products LtdINE0QSB01016 · Market cap Rs 45.9 Cr
- Royal Sense LtdINE0QQG01019 · Market cap Rs 37.5 Cr
- Centenial Surgical Suture LtdINE405H01018 · Market cap Rs 26 Cr
- Transpact Enterprises LtdINE06YD01010 · Market cap Rs 3.7 Cr
Other Healthcare companies of a similar market capitalisation
- Vijaya Diagnostic Centre LimitedVIJAYA · Market cap Rs 15,066 Cr
- Jubilant Pharmova LimitedJUBLPHARMA · Market cap Rs 14,947 Cr
- Poly Medicure LimitedPOLYMED · Market cap Rs 14,818 Cr
- Indegene LimitedINDGN · Market cap Rs 14,272 Cr
- Natco Pharma LimitedNATCOPHARM · Market cap Rs 14,097 Cr
- Concord Biotech LimitedCONCORDBIO · Market cap Rs 12,874 Cr
- Rainbow Childrens Medicare LimitedRAINBOW · Market cap Rs 12,155 Cr
- Blue Jet Healthcare LimitedBLUEJET · Market cap Rs 8,735 Cr
Companies are grouped mechanically from the exchange classification and listed by market capitalisation. This is a comparison set, not a ranking or recommendation.